Insmed's DPP1 inhibitor Brinsupri (brensocatib) has been recommended by the CHMP for the treatment of patients aged 12 and ...

Mayo Clinic researchers have identified a molecular "switch" in lung cells that helps them decide when to repair tissue and ...

The oral targeted therapy sevabertinib led to tumor reduction and manageable side effects in patients with HER2-mutant ...

Pulmonary fibrosis is a deadly disease in which the lungs become thickened and scarred, gradually losing their ability to ...

Spotting ILDs may be challenging. Symptoms such as a dry cough, shortness of breath, and unexplained weight loss may go ...

Lung cancer remains the leading cause of cancer-related death in the United States. The good news is that early detection ...

Scientists at UCSF identified a key cellular switch that plays a large role in pulmonary fibrosis, and found a way of ...

Indiana farmers are expected to harvest 10.6 million acres of corn and soybeans this fall, powering the state’s agri-industry ...

Chronic cough, breathlessness or pollution exposure may signal underlying lung disease. Here's when you should consider a ...

Background Compared with cytotoxic chemotherapy, the efficacy and safety of immune checkpoint inhibitors (ICIs) for patients ...

Enhertu significantly improved IDFS compared to Kadcyla, with a 53% risk reduction in invasive disease or death in high-risk, ...